drugset / Trial / NCT00165815

The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

NCT00165815

Phase 3 Completed Eisai Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomised, double-blind, 3-arm parallel group study comparing Aricept® with placebo.

Timeline

Start
2002-08
Primary completion
Completion
2005-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule

Indications